The value of perioperative imaging in patients with uterine sarcomas

Gynecologic Oncology

Volumn 115, Issue 1, 2009, Pages 37-40

  Nugent, Elizabeth K ^a   Zighelboim, Israel ^a   Case, Ashley S ^a   Gao, Feng ^a   Thaker, Premal H ^a   Rader, Janet S ^a   Mutch, David G ^a   Massad, L Stewart ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Imaging; Sarcoma; Staging; Uterine cancer

Indexed keywords

GEMCITABINE; HORMONE; IFOSFAMIDE; MESNA; PLATINUM DERIVATIVE; TAXANE DERIVATIVE;

ADULT; AGED; ARTICLE; BONE SCINTISCANNING; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CARCINOSARCOMA; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; ENDOMETRIUM SARCOMA; FEMALE; HUMAN; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; METASTASIS; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THORAX RADIOGRAPHY; UTERUS SARCOMA;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSTIC IMAGING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; PERIOPERATIVE CARE; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; SARCOMA; TOMOGRAPHY, X-RAY COMPUTED; UTERINE NEOPLASMS; YOUNG ADULT;

EID: 69249221264     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.06.013     Document Type: Article

References (13)

1. Giuntoli R., Metzinger D., DiMarco C., et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol. Oncol. 106 (2007) 82-88
2. Moskovic E., MacSweeny E., Law M., and Price A. Survivial, patterns of spread and prognostic factors in uterine sarcoma: a study of 76 patients. Br. J. Radiol. 66 791 (1993) 1009-1015
3. Greer B, Koh W, Abu-Rustum N, Bookman MA, et-al. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Uterine Neoplasm. February 16, 2009. Available at www.nccn.org/professionals/physician_gls/PDF/uterine.pdf. Accessed on March 15, 2009.
4. Major F., Blessing J., Silverberg S., et al. Prognostic factors in early stage uterine sarcoma. Cancer 71 Suppl 4 (1993) 1902-1909
5. Dinh T., Oliva E., Fuller A., Lee H., and Goodman A. The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital. Gynecol. Oncol. 92 (2004) 648-652
6. Iglehart J.K. Health insurers and medical-imaging policy: a work in progress. N. Engl. J. Med. 360 (2009) 1030-1037
7. McLeod A., Zornoza J., and Shirkhoda A. Leiomyosarcoma: computed tomographic findings. Radiology 152 (1984) 133-136
8. Rha S., Byun J., Jung S., et al. CT and MRI of uterine sarcomas and their mimickers. Am. J. Radiol. 181 (2003) 1369-1374
9. Bansal N., Herzog T.J., Brunner-Brown A., et al. The utility and cost effectiveness of preoperative computed tomography for patients with uterine malignancies. Gynecol. Oncol. 111 (2008) 208-212
10. Omura G., Blessing J., Major F., et al. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group study. J. Clin. Oncol. 3 9 (1985) 1240-1246
11. Hensley M., Maki R., Venkatraman E., et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J. Clin. Oncol. 20 (2002) 2824-2831
12. Giuntoli R.L., Garrett-Mayer E., Bristow R.E., and Gostout B.S. Secondary cytoreduction in the management of recurrent uteine leiomyosarcoma. Gynecol. Oncol. 106 (2007) 82-88
13. Leath C., Huh W., Hyde J., et al. A multi-institutional review of outcomes of endometrial stromal sarcoma. Gynecol. Oncol. 105 (2007) 630-634